Back

Broccoli Sprouts (Sulforaphane)

Broccoli sprouts are best known for containing high levels of sulforaphane, extensively studied for its antioxidant and detoxification properties.

Evidence · Grade D
Meta-analysis availableSystematic review availableHuman trial evidenceTraditional useInteraction riskNeeds more research

Young broccoli sprouts deliver 10-100x the sulforaphane of mature broccoli; researched for autism behavior and cancer chemoprevention.

Broccoli sprouts are young broccoli plants harvested typically after 3-5 days, known for their concentrated levels of glucoraphanin, a precursor to sulforaphane. Sulforaphane appears to be the primary bioactive compound responsible for many of the studied health benefits. People often consume broccoli sprouts in their raw form, add them to salads and smoothies, or take them as concentrated supplements. They are commonly explored for their potential roles in detoxification and antioxidant support.

Quick answer

What it is: Broccoli sprouts are young broccoli plants harvested typically after 3-5 days, known for their concentrated levels of glucoraphanin, a precursor to sulforaphane.

May support:Estrogen Dominance, Prediabetes, Insulin Resistance, H. pylori Infection, Autism Spectrum, Cancer (Adjunctive Support)

Evidence:Evidence · Grade D

Evidence Summary

Evidence · Grade D

Evidence for broccoli sprouts and sulforaphane includes numerous preclinical studies and a growing number of human trials, often small or with surrogate markers. The existence of human trials exploring various outcomes, combined with strong mechanistic understanding, lends some support, though significant clinical proof is often still emerging, contributing to a 'D' grade.

Last reviewed · Jun 2026

Have you tried Broccoli Sprouts (Sulforaphane)?

Vote in 5 seconds. Add details if you want.

Your experience for Estrogen Dominance:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Broccoli Sprouts (Sulforaphane)

Search on Reddit →

Latest News

Latest news on Broccoli Sprouts (Sulforaphane)

More on Google News →

Health Videos

Health videos on Broccoli Sprouts (Sulforaphane)

More on YouTube

Why It Works

Sulforaphane, derived from broccoli sprouts, appears to work by activating cellular defense pathways, particularly the Nrf2 pathway, which in turn upregulates antioxidant and detoxification enzymes.

How it works in more detail

The primary mechanism appears to involve sulforaphane's ability to act as an indirect antioxidant by activating the Nrf2 (nuclear factor erythroid 2-related factor 2) signaling pathway. Nrf2 activation leads to the transcription of genes encoding phase II detoxification enzymes (e.g., glutathione S-transferases, quinone reductase) and antioxidant proteins (e.g., heme oxygenase-1), which help protect cells from oxidative damage and remove harmful compounds. This action may contribute to cellular resilience and inflammation modulation. Much of the detailed understanding of these mechanisms stems from preclinical research.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
3–6 g/day broccoli sprout powder or 30–60 mg sulforaphane.
Research dosage range
20–60 mg sulforaphane equivalent per day or 400 mg glucoraphanin per day, often delivered as sprout powder or extract.
Typical onset
Some acute effects on detoxification markers or antioxidant capacity have been observed within hours or days in research settings. However, for potential long-term health benefits, consistent intake over weeks to months is typically implied by research models.
Typical forms
fresh sprouts, powdered extract, capsule
Quality markers
A quality broccoli sprout supplement should specify its sulforaphane potential or glucoraphanin content. Some products may contain myrosinase, the enzyme needed to convert glucoraphanin to sulforaphane; if not, heating can destroy myrosinase, impacting sulforaphane formation. Third-party testing for purity and potency, including checks for contaminants, is also a marker of quality.
Medication interactions
  • Warfarin (potential interaction due to vitamin K, though minimal in sprouts)
  • Thyroid medications (potential for goitrogenic effects with very high intake)
Avoid if
  • Known allergy to cruciferous vegetables
  • Individuals on blood thinners (due to potential vitamin K content, though low in sprouts)

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

3–6 g/day broccoli sprout powder or 30–60 mg sulforaphane.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Glucoraphanin, sulforaphane, myrosinase.

Traditional use

Identified by Johns Hopkins research in the 1990s; the cruciferous lineage is ancient.

Safety

Safety warnings

GI discomfort possible at high doses. Caution in hypothyroidism (large raw amounts may be goitrogenic).

Avoid if

  • Known allergy to cruciferous vegetables
  • Individuals on blood thinners (due to potential vitamin K content, though low in sprouts)

Medication interactions

  • Warfarin (potential interaction due to vitamin K, though minimal in sprouts)
  • Thyroid medications (potential for goitrogenic effects with very high intake)

Reported side effects

  • Mild gastrointestinal upset (gas, bloating)
  • Allergic reactions (rare)

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (D)

Evidence for broccoli sprouts and sulforaphane includes numerous preclinical studies and a growing number of human trials, often small or with surrogate markers. The existence of human trials exploring various outcomes, combined with strong mechanistic understanding, lends some support, though significant clinical proof is often still emerging, contributing to a 'D' grade.

Filter by source type

Meta-Analyses(1)

Pooled analyses across multiple human trials.

Very High Quality
  • Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.

    Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M · Molecular autism · 2022 · n=7450

    There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network meta-analysis investigated pharmacological and dietary-supplement treatments for ASD. We searched for randomized-controlled-trials (RCTs) with a minimum duration of seven days in ClinicalTrials.gov, EMBASE, MEDLINE, PsycINFO, WHO-ICTRP (from inception up to July 8, 2018), CENTRAL and PubMed (up to November 3, 2021). The co-primary outcomes were core symptoms (social-communication difficulties-SCD, repetitive behaviors-RB, overall core symptoms-OCS) measured by validated scales and standardized-mean-differences (SMDs). Associated symptoms, e.g., irritability/aggression and attention-deficit/hyperactivity disorder (ADHD) symptoms, dropouts and important side-effects, were investigated as secondary outcomes. Studies in children/adolescents and adults were analyzed separately in random-effects pairwise and network meta-analyses. We analyzed data for 41 drugs and 17 dietary-suppleme

    Meta-AnalysisPubMedVery High Quality

Systematic Reviews(2)

Structured reviews of the full body of evidence (incl. Cochrane).

Very High Quality
  • The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future.

    Persico AM, Asta L, Chehbani F, Mirabelli S, Parlatini V, Cortese S · Progress in neuro-psychopharmacology & biological psychiatry · 2025

    Part I of this systematic review summarized the state-of-the-art of pediatric psychopharmacology for Autism Spectrum Disorder (ASD), a severe and lifelong neurodevelopmental disorder. The purpose of this Part II follow-up article is to provide a systematic overview of the experimental psychopharmacology of ASD. To this aim, we have first identified in the Clinicaltrials.gov website all the 157 pharmacological and nutraceutical compounds which have been experimentally tested in children and adolescents with ASD using the randomized placebo-controlled trial (RCT) design. After excluding 24 drugs already presented in Part I, a systematic review spanning each of the remaining 133 compounds was registered on Prospero (ID: CRD42023476555), performed on PubMed (August 8, 2024), and completed with EBSCO, PsycINFO (psychology and psychiatry literature) and the Cochrane Database of Systematic reviews, yielding a total of 115 published RCTs, including 57 trials for 23 pharmacological compounds an

    Systematic ReviewPubMedVery High Quality
  • Use of food and food-derived products in the treatment of gastritis: A systematic review.

    Duque-Buitrago LF, Tornero-Martínez A, Loera-Castañeda V, Mora-Escobedo R · Critical reviews in food science and nutrition · 2023

    Gastritis is the acute or chronic inflammation of gastric mucosa and is triggered by diverse factors. Treatments used for non-bacterial gastritis include proton pump inhibitors, histamine H2 receptor inhibitors, and antacids, and their use is linked to various side effects. Research on alternative therapeutics using food or food-based products is extensive, mostly in preclinical research. We aimed at documenting the clinical advances in food-based therapies as alternative therapeutics for gastritis. Articles with information on the treatment of gastritis with food or food-based products published until December 1, 2020 were identified through a systematic search in PubMed Medline Database. Additionally, references of retrieved articles were screened for relevant reviews and meta-analyses. Two investigators independently selected and reviewed the titles and abstracts of articles and extracted the study characteristics (PICO framework) and key findings. Dual quality assessment and data e

    Systematic ReviewPubMedVery High Quality

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Broccoli Extract Supplementation and Gastrointestinal Health in Older Adults With Active Alcohol Use and Low Diet Quality

    n=40 · NCT05902754 · COMPLETED · COMPLETED

    Chronic alcohol consumption leads to perturbations in gut microbiome balance (dysbiosis) and disruption of gut barrier integrity. As a result, bacteria, toxins, and metabolites can enter the blood stream and reach distant organs, triggering inflammation and oxidative stress. Through this mechanism gut leak is closely related to the onset of metabolic diseases, such as nonalcoholic fatty liver disease (NAFLD) and diabetes. Despite the prominent role of diet and alcohol in the pathogenesis of metabolic diseases, there is a lack of treatments to mitigate their effects in triggering systemic inflammation and oxidative stress. Novel treatments using generally recognized as safe (GRAS) compounds focused on restoring the intestinal barrier to mitigate metabolite endotoxemia are sorely needed. This project will test the potential of broccoli sprouts extract (BSE) as a GRAS treatment to minimize the combined effect of poor nutrition and alcohol on the gut. Broccoli sprouts are rich in sulforaphane, a bioactive compound derived from the glucosinolate glucoraphanin with anti-inflammatory and antioxidant proprieties. BSE supplementation has been used in preclinical and clinical studies as a health- promoting food, showing significant positive changes in the gut microbiota composition, protection against colitis, cardiometabolic improvement, and lower inflammation. We believe that BSE is a viable alternative therapeutic approach for patients who are resistant to lifestyle changes such as healthy eating and reducing alcohol use. Our purpose is to test BSE supplementation in human subjects with poor nutrition compounded by alcohol use, specifically in older adults who we believe will receive greater benefit from this approach. At the completion of the proposed study, we expect to have determined that treatments using generally recognized as safe (GRAS) compounds can be useful to restore the gut barrier integrity, and as consequence of reduced gut leak we expect to observe lower inflammation and oxidative stress.

    Clinical TrialClinicalTrials.govModerate Quality

Evidence Summaries(1)

Curated cross-source summaries (TRIP Database and similar).

High Quality
  • Sulforaphane Monograph

    Natural Medicines Database

    This monograph provides comprehensive, evidence-based data on sulforaphane, including its efficacy, safety, mechanism of action, and interactions. It includes information relevant to various health conditions, though specific recommendations for estrogen dominance may not be a primary focus.

    Evidence SummaryNatural Medicines DatabaseHigh Quality

Limitations: Existing human trials are often small, heterogeneous in design, and vary in the form and dose of broccoli sprout or sulforaphane intervention. Many findings are dose-dependent, and the bioavailability of sulforaphane can differ significantly based on the preparation method. Large-scale, well-controlled human clinical trials with clinically relevant endpoints are generally lacking.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Broccoli Sprouts (Sulforaphane)?

Help others see what actually works.